Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label, Single Arm, Multicenter Study to Evaluate the Safety and Immunogenicity of HX575 Epoetin Alfa in the Treatment of Anemia Associated With Chronic Kidney Disease in Pre-dialysis and Dialysis Patients

NCT01576341 is registered in ClinicalTrials.gov with Sandoz as lead sponsor.

NCT NCT01576341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01576341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label, Single Arm, Multicenter Study to Evaluate the Safety and Immunogenicity of HX575 Epoetin Alfa in the Treatment of Anemia Associated With Chronic Kidney Disease in Pre-dialysis and Dialysis Patients
Lead sponsor
Sandoz
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2012
Completion date
June 30, 2015
Enrollment
417 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease